Glenmede Trust’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-50,177
| Closed | -$290K | – | 2666 |
|
2016
Q2 | $290K | Sell |
50,177
-950
| -2% | -$5.49K | ﹤0.01% | 1079 |
|
2016
Q1 | $309K | Hold |
51,127
| – | – | ﹤0.01% | 1045 |
|
2015
Q4 | $466K | Sell |
51,127
-13,859
| -21% | -$126K | ﹤0.01% | 942 |
|
2015
Q3 | $366K | Buy |
64,986
+36,000
| +124% | +$203K | ﹤0.01% | 1023 |
|
2015
Q2 | $321K | Sell |
28,986
-7,000
| -19% | -$77.5K | ﹤0.01% | 1101 |
|
2015
Q1 | $563K | Hold |
35,986
| – | – | ﹤0.01% | 911 |
|
2014
Q4 | $546K | Buy |
35,986
+2,000
| +6% | +$30.3K | ﹤0.01% | 909 |
|
2014
Q3 | $365K | Sell |
33,986
-1,000
| -3% | -$10.7K | ﹤0.01% | 980 |
|
2014
Q2 | $533K | Hold |
34,986
| – | – | ﹤0.01% | 847 |
|
2014
Q1 | $632K | Sell |
34,986
-1,200
| -3% | -$21.7K | 0.01% | 808 |
|
2013
Q4 | $502K | Sell |
36,186
-800
| -2% | -$11.1K | 0.01% | 852 |
|
2013
Q3 | $387K | Hold |
36,986
| – | – | ﹤0.01% | 899 |
|
2013
Q2 | $288K | Buy |
+36,986
| New | +$288K | ﹤0.01% | 965 |
|